Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Glaukos Corp (GKOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,516,647
  • Shares Outstanding, K 34,290
  • Annual Sales, $ 114,400 K
  • Annual Income, $ 4,520 K
  • 36-Month Beta 1.33
  • Price/Sales 13.18
  • Price/Cash Flow 156.14
  • Price/Book 12.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.26 +18.71%
on 06/06/17
44.67 -0.98%
on 06/23/17
+5.22 (+13.38%)
since 05/23/17
3-Month
36.51 +21.14%
on 05/19/17
52.48 -15.72%
on 04/04/17
-4.67 (-9.55%)
since 03/23/17
52-Week
26.96 +64.06%
on 06/27/16
52.49 -15.74%
on 03/02/17
+15.48 (+53.84%)
since 06/23/16

Most Recent Stories

More News
Combining Implantation of Glaukos iStent inject(R) Trabecular Micro-Bypass with Topical Travoprost Provides Sustained IOP Reduction and Favorable Safety Profile, According to New Study

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the...

GKOS : 44.23 (+0.55%)
Glaukos Announces Participation in William Blair Growth Stock Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the...

GKOS : 44.23 (+0.55%)
Study Reveals Potential Cost Efficiency of Using Two Glaukos iStent(R) Trabecular Micro-Bypass Stents to Treat Elevated IOP in Glaucoma Patients

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the...

GKOS : 44.23 (+0.55%)
Glaukos Corporation Announces First Quarter 2017 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the...

GKOS : 44.23 (+0.55%)
Glaukos Announces Participation in Bank of America Merrill Lynch 2017 Health Care Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the...

GKOS : 44.23 (+0.55%)
Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform...

GKOS : 44.23 (+0.55%)
Cerner (CERN) Earnings and Revenues Beat Estimates in Q1

Cerner Corp (CERN) reported adjusted first-quarter 2017 earnings of 56 cents per share, beating the Zacks Consensus Estimate of 53 cents.

CERN : 68.32 (+1.46%)
GKOS : 44.23 (+0.55%)
AVGR : 0.42 (-8.70%)
FLDM : 3.90 (-4.88%)
CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y

CONMED Corporation (CNMD) reported first-quarter 2017 adjusted earnings of 38 cents per share, beating the Zacks Consensus Estimate by 4 cents.

GKOS : 44.23 (+0.55%)
CNMD : 51.42 (-0.27%)
AVGR : 0.42 (-8.70%)
FLDM : 3.90 (-4.88%)
Stryker (SYK) Earnings and Revenues Beat Estimates in Q1

Stryker Corp (SYK) reported adjusted earnings of $1.48 per share in the first quarter of 2017, which comfortably beat the Zacks Consensus Estimate by 5 cents.

SYK : 141.12 (-0.07%)
GKOS : 44.23 (+0.55%)
AVGR : 0.42 (-8.70%)
FLDM : 3.90 (-4.88%)
International Study Shows Two Glaukos iStent(R) Trabecular Micro-Bypass Stents and One Topical Medication Deliver Sustained IOP Reduction

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the...

GKOS : 44.23 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe,...

See More

Support & Resistance

2nd Resistance Point 45.40
1st Resistance Point 44.82
Last Price 44.23
1st Support Level 43.50
2nd Support Level 42.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.